
Get in Touch
connect@vediclifesciences.com
EU MDR Webinar: CE Marking for Medical Devices
EU MDR Webinar: CE Marking for Medical Devices
EU MDR Webinar: CE Marking for Medical Devices

Event Overview:
Vedic Lifesciences successfully hosted the webinar EU MDR CE Marking for Medical Devices: From Strategy to Approval, an expert-led session designed to help medical device companies navigate the complexities of the evolving European regulatory landscape. The webinar provided actionable insights into the EU Medical Device Regulation (EU MDR) framework, regulatory strategy development, and the critical steps required to achieve successful CE Marking for medical devices.
As EU MDR requirements continue to reshape market access pathways, the session offered practical guidance for manufacturers, regulatory professionals, and industry stakeholders seeking a clearer route from strategy to approval.
Event Overview:
Vedic Lifesciences successfully hosted the webinar EU MDR CE Marking for Medical Devices: From Strategy to Approval, an expert-led session designed to help medical device companies navigate the complexities of the evolving European regulatory landscape. The webinar provided actionable insights into the EU Medical Device Regulation (EU MDR) framework, regulatory strategy development, and the critical steps required to achieve successful CE Marking for medical devices.
As EU MDR requirements continue to reshape market access pathways, the session offered practical guidance for manufacturers, regulatory professionals, and industry stakeholders seeking a clearer route from strategy to approval.
Event Overview:
Vedic Lifesciences successfully hosted the webinar EU MDR CE Marking for Medical Devices: From Strategy to Approval, an expert-led session designed to help medical device companies navigate the complexities of the evolving European regulatory landscape. The webinar provided actionable insights into the EU Medical Device Regulation (EU MDR) framework, regulatory strategy development, and the critical steps required to achieve successful CE Marking for medical devices.
As EU MDR requirements continue to reshape market access pathways, the session offered practical guidance for manufacturers, regulatory professionals, and industry stakeholders seeking a clearer route from strategy to approval.
Key Discussion Points
Key Discussion Points
Understanding EU MDR requirements for CE marking of medical devices
Key differences between MDD vs EU MDR compliance
Common reasons for delays in EU MDR approvals
What Notified Bodies look for in clinical evaluation and technical documentation
Strategies to strengthen your regulatory submission and clinical evidence
How to streamline your pathway to faster CE certification in Europe
Speakers
Speakers


Dr. Engin Çamer, MD
Dr. Engin Çamer, MD
Clinical Unit Manager
Clinical Unit Manager
SZUTEST (Notified Body 2975)
SZUTEST (Notified Body 2975)
Dr. Engin Çamer is a medical doctor with over 15 years of clinical experience and more than six years of expertise in Medical Device Regulation, where he has worked as an internal clinician and final clinical reviewer.
He currently serves as the Clinical Unit Manager at SZUTEST Konformitätsbewertungsstelle GmbH, a Notified Body under EU MDR. Dr. Çamer actively contributes to the European regulatory ecosystem as a member of multiple Team-NB working groups, including the Clinical Harmonization Group, Article 61(10) Working Group, Annex XVI Devices Working Group, and the Lifetime Working Group.
His experience offers a rare Notified Body perspective on how clinical evidence, regulatory strategy, and conformity assessment intersect - making this session highly valuable for organizations seeking successful CE marking under EU MDR.
Dr. Engin Çamer is a medical doctor with over 15 years of clinical experience and more than six years of expertise in Medical Device Regulation, where he has worked as an internal clinician and final clinical reviewer.
He currently serves as the Clinical Unit Manager at SZUTEST Konformitätsbewertungsstelle GmbH, a Notified Body under EU MDR. Dr. Çamer actively contributes to the European regulatory ecosystem as a member of multiple Team-NB working groups, including the Clinical Harmonization Group, Article 61(10) Working Group, Annex XVI Devices Working Group, and the Lifetime Working Group.
His experience offers a rare Notified Body perspective on how clinical evidence, regulatory strategy, and conformity assessment intersect - making this session highly valuable for organizations seeking successful CE marking under EU MDR.
This session concluded with an engaging Q&A discussion, providing attendees with practical perspectives on real-world EU MDR challenges and implementation considerations.
This session concluded with an engaging Q&A discussion, providing attendees with practical perspectives on real-world EU MDR challenges and implementation considerations.
Related Webinars
Related Webinars

Vedic Lifesciences — Where Innovation Meets Evidence
Clinical trials, regulatory clarity and brand growth for global health innovators.
Explore Now
Vedic Lifesciences scoops Nutra Ingredients research project award.
© 2025 Vedic Lifescience Pvr Ltd. All Rights Reserved.
Designed and Developed with ❤️ at Codesis

Vedic Lifesciences — Where Innovation Meets Evidence
Clinical trials, regulatory clarity and brand growth for global health innovators.
Explore Now
Vedic Lifesciences scoops Nutra Ingredients research project award.
© 2025 Vedic Lifescience Pvr Ltd. All Rights Reserved.
Designed and Developed with ❤️ at Codesis

Vedic Lifesciences — Where Innovation Meets Evidence
Clinical trials, regulatory clarity and brand growth for global health innovators.
Explore Now
Vedic Lifesciences scoops Nutra Ingredients research project award.
© 2025 Vedic Lifescience Pvr Ltd. All Rights Reserved.
Designed and Developed with ❤️ at Codesis
Want to Join Vedic? Reach out to our HR


